Cargando…

The evidence remains clear: SARS-CoV-2 emerged via the wildlife trade

Detalles Bibliográficos
Autor principal:	Garry, Robert F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704731/ https://www.ncbi.nlm.nih.gov/pubmed/36355862 http://dx.doi.org/10.1073/pnas.2214427119

Ejemplares similares

Surveillance for Emerging Biodiversity Diseases of Wildlife
por: Grogan, Laura F., et al.
Publicado: (2014)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
por: Tonk, Miray, et al.
Publicado: (2021)

SARS-CoV-2 Emergency and Long-Term Cognitive Impairment in Older People
por: Rizzo, Maria Rosaria, et al.
Publicado: (2021)

Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
por: Rahimi, Farid, et al.
Publicado: (2021)

Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
por: Baldari, Cosima T., et al.
Publicado: (2023)

Wildlife Trade and Global Disease Emergence
por: Karesh, William B., et al.
Publicado: (2005)

T Cells: Warriors of SARS-CoV-2 Infection
por: de Candia, Paola, et al.
Publicado: (2021)

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022)

Understanding Laboratory Testing for SARS-CoV-2
por: Cheema, Ritu, et al.
Publicado: (2021)

Rapid deployment of SARS-CoV-2 testing: The CLIAHUB
por: Crawford, Emily D., et al.
Publicado: (2020)

Nano-targeting lessons from the SARS-CoV-2
por: Ribeiro, I.R.S., et al.
Publicado: (2021)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Wildlife Trade and the Emergence of Infectious Diseases
por: Swift, Louise, et al.
Publicado: (2007)

Beyond banning wildlife trade: COVID-19, conservation and development
por: Roe, Dilys, et al.
Publicado: (2020)

Understanding China’s wildlife markets: Trade and tradition in an age of pandemic
por: Zhu, Annah, et al.
Publicado: (2020)

Potential Applications of Plant Biotechnology against SARS-CoV-2
por: Capell, Teresa, et al.
Publicado: (2020)

SARS-CoV-2–A Tough Opponent for the Immune System
por: Nasab, Mahsa Golshani, et al.
Publicado: (2020)

Virus Eradication and Synthetic Biology: Changes with SARS-CoV-2?
por: Tournier, Jean-Nicolas, et al.
Publicado: (2021)

Are Older People Really More Susceptible to SARS-CoV-2?
por: Zhang, Shuo, et al.
Publicado: (2022)

Heme, Heme Oxygenase-1, Statins, and SARS-CoV-2
por: Stevenson, David K., et al.
Publicado: (2023)

Spying on SARS-CoV-2 with Fluorescent Tags and Protease Reporters
por: To, Tsz-Leung, et al.
Publicado: (2023)

SARS‐CoV‐2, bacterial co‐infections, and AMR: the deadly trio in COVID‐19?
por: Bengoechea, Jose A, et al.
Publicado: (2020)

Assessing the risks of SARS-CoV-2 in wildlife
por: Delahay, R. J., et al.
Publicado: (2021)

SARS-CoV-2 and the next generations: which impact on reproductive tissues?
por: Zupin, Luisa, et al.
Publicado: (2020)

SARS-CoV-2: Cross-scale Insights from Ecology and Evolution
por: Snedden, Celine E., et al.
Publicado: (2021)

Why Does SARS-CoV-2 Infection Induce Autoantibody Production?
por: Macela, Ales, et al.
Publicado: (2021)

The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
por: Sarkar, Amar, et al.
Publicado: (2021)

The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required
por: Goldman, Michel
Publicado: (2022)

Targeting SARS-CoV-2 papain-like protease in the postvaccine era
por: Ton, Anh-Tien, et al.
Publicado: (2022)

Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
por: Fraser, Rupsha, et al.
Publicado: (2023)

Evidence of SARS-CoV-2 Related Coronaviruses Circulating in Sunda pangolins (Manis javanica) Confiscated From the Illegal Wildlife Trade in Viet Nam
por: Nga, Nguyen Thi Thanh, et al.
Publicado: (2022)

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
por: Facente, Shelley N., et al.
Publicado: (2021)

Summarizing the Evidence on the International Trade in Illegal Wildlife
por: Rosen, Gail Emilia, et al.
Publicado: (2010)

Is Sexual Route a Matter of Concern for the SARS-CoV-2/COVID-19?
por: Patel, Shailesh Kumar, et al.
Publicado: (2020)

SARS-CoV-2 another kind of liver aggressor, how does it do that?
por: Lozano-Sepulveda, Sonia A., et al.
Publicado: (2020)

The importance of naturally attenuated SARS‐CoV‐2in the fight against COVID‐19
por: Armengaud, Jean, et al.
Publicado: (2020)

Cautionary note on contamination of reagents used for molecular detection of SARS-CoV-2
por: Huggett, Jim F, et al.
Publicado: (2020)

SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity
por: Mullbacher, Arno, et al.
Publicado: (2020)

Slaying SARS-CoV-2 One (Single-domain) Antibody at a Time
por: Czajka, Timothy F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5i4ivh97ipic405avga5jjrh7n